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1 The effect of 1-aminocyclopropanecarboxylic acid (ACPC), a partial agonist at the glycine site of the
N-methyl-D-aspartate (NMDA) receptor complex that exhibits neuroprotective, anxiolytic and
antidepressant-like actions, was investigated in a functional assay for presynaptic NMDA receptors.
2 NMDA (100 giM) produced a 36% increase of tritium efflux above basal efflux in rat hippocampal
synaptosomes preincubated with [3H]-noradrenaline ([3H]-NA), reflecting a release of tritiated
noradrenaline. This effect was prevented by 1O Mm 7-chlorokynurenic acid, an antagonist of the glycine
site of the NMDA receptor.
3 Glycine enhanced the effect of NMDA with Emaxc and EC50 values of 84+11% and 1.82 + 0.04 gM,
respectively. ACPC potentiated the effect of NMDA on tritium overflow with a lower EC50 (43 + 6 nM)
and a lower maximal effect (E=,,, =40 +9%) than glycine. Furthermore, ACPC (0.1 Mm) shifted the EC50
of glycine from 1.82 gM to > 3 mM.
4 These results show that ACPC can reduce the potentiation by glycine of NMDA-evoked [3 1-NA
release and hence, may act as an antagonist at the glycine site of presynaptic hippocampal NMDA
receptors when the concentration of glycine is high.
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Introduction
The N-methyl-D-aspartate (NMDA) subtype of excitatory
amino acid receptors is a ligand-gated ion channel that con-
tains discrete but interdependent functional domains, each
with separate ligand binding sites (recently reviewed in McBain
& Mayer, 1994). Among others there is a transmitter re-
cognition site for acidic amino acids such as L-glutamate; a
cation channel with a unique voltage-dependent regulation by
magnesium; a polyamine site; and a recognition site for neutral
animo acids such as glycine. The binding of glycine to its re-
cognition site on the NMDA receptor is strychnine-insensitive
and was initially shown to augment the electrophysiological
actions of NMDA in cultured neurones (Johnson & Ascher,
1987). Subsequent studies in both Xenopus oocytes expressing
NMDA-gated cation channels (Kleckner & Dingledine, 1988;
Lerma et al., 1990) and primary cultures of the rat visual
cortex (Huettner, 1989) have demonstrated that occupation of
the glycine site by an agonist is an absolute requirement for
NMDA receptor activation and that glycine acts as a co-
agonist at this receptor (Kleckner & Dingledine, 1988).
1-Aminocyclopropanecarboxylic acid (ACPC) is a specific
high affinity ligand (Ki - 32 nM) at strychnine-insensitive glycine
sites (Marvizon et al., 1989) that has been reported to exhibit
partial agonist activity in both neurochemical (Marvizon et al.,
1989) and electrophysiological (Watson & Lanthorn, 1990;
Priestley & Kemp, 1994) studies. It has been hypothesized that if
the glycine co-agonist site needs to be occupied for the activation
of the NMDA receptor complex and this is also an absolute
requirement in vivo, then a partial agonist such as ACPC could
function as an NMDA antagonist in vivo (Skolnick et al., 1989;
Trullas et al., 1989). In agreement with this hypothesis, and si-
milarly to both competitive NMDA antagonists and use-de-
pendent channel blockers, ACPC exhibited anticonvulsant
(Skolnick et al., 1989), neuroprotective (Von Lubitz et al., 1992),
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anxiolytic (Trullas et al., 1989), and antidepressant (Trullas &
Skolnick, 1990) actions in animal models. To investigate the
mechanisms involved in the functional NMDA receptor an-
tagonist properties ofACPC, the present study was designed to
evaluate the effects of this compound on NMDA receptor
function using an in vitro functional assay for NMDA receptors
(Pittaluga & Raiteri, 1990).
Previous investigations have shown that NMDA-sensitive
receptors are present on noradrenergic axon terminals of rat
cerebral cortex and hippocampus (Pittaluga & Raiteri, 1990;
Fink et al., 1990). Activation of these presynaptic receptors
results in a Ca2+-dependent [3H]-noradrenaline ([3H]-NA) re-
lease and their pharmacological characterization indicates that
they are indistinguishable from the NMDA receptors de-
scribed in electrophysiological studies (Pittaluga & Raiteri,
1990; 1992; Gothert & Fink, 1991; Raiteri et al., 1992; Wang et
al., 1992). The NMDA-stimulated [3H]-NA release is po-
tentiated by glycine and is blocked by Mg2e and selective
NMDA antagonists (Pittaluga & Raieri, 1990; 1992; G6thert
& Fink, 1991; Wang et al., 1992).
Using this functional assay for presynaptic NMDA re-
ceptors, we now show that ACPC reduces the facilitatory effect
of glycine on NMDA-evoked [3H]-NA release. This result
provides further evidence to support the hypothesis that ACPC
may act as a functional NMDA receptor antagonist.
Methods
Preparation of synaptosomes
Male Sprague-Dawley rats (3-4 months) were housed 3 per
cage and maintained on a 12 h light/dark cycle with food and
water freely available. Animals were killed by decapitation and
the brains were quickly removed and kept on ice during dis-
section. Crude hippocampal synaptosomes were prepared ac-
cording to Gray & Whittaker (1962). Briefly, the hippocampus
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was rapidly dissected on ice and homogenized with a Teflon-
glass Potter homogenizer in 40 volumes of 0.32 M sucrose
buffered at pH 7.4 with sodium phosphate (0.01 M). Homo-
genates were centrifuged at 1000 g for 5 min, the pellet was
discarded and the supernatant was again centrifuged at
12,000 g for 20 min. The crude synaptosomal pellet was then
resuspended in a standard medium having the following
composition (in mM): NaCl 125, KC1 3, MgSO4 1.2, CaCl2 1.2,
NaHCO3 22, NaH2PO4 1, glucose 10, pH 7.2 to 7.4 and con-
tinuously aerated with 95% 02 and 5% CO2 at 37'C.
Neurotransmitter release
The release of [3H]-NA from synaptosomes was measured in a
continuous superfusion system as described by Raiteri et al.
(1974). Briefly, after incubation of synaptosomes (15 min,
370C) in the presence of [3H]-NA (0.04 yM, 39 Ci mmol-')
aliquots of the synaptosomal suspension (0.24 mg protein/
chamber) were distributed on 0.65 ym Millipore filters and
placed at the bottom of a set of parallel superfusion chambers.
After 20 min of superfusion the standard medium was replaced
with a medium without MgSO4. Two-minute fractions were
collected starting at t= 37.5 min (t = 0 being the beginning of
superfusion). The amount of radioactivity released into each
fraction was calculated as the percentage of the total sy-
naptosomal tritium at the start of the fraction collected. Tri-
tium release in each fraction was expressed as a ratio over the
first fraction collected (Fx/F1). Preliminary studies indicated
that the maximal effects of drugs on tritium release were
reached in the third fraction (results not shown). Thus, the
effects of drugs on tritium release were evaluated by calculating
the ratio of percentage tritium release in fraction 3 (F3), cor-
responding to the maximal effect, and the tritium release in the
first fraction collected (F1, in which no drugs were present).
This F3/F1 ratio was compared with the corresponding F3/F1
ratio obtained for the respective control groups. NMDA,
glycine and ACPC were added at the end of the first fraction.
In experiments evaluating the effects of ACPC on the po-
tentiation by glycine of NMDA-evoked tritium release, ACPC
was added 10 min before NMDA and glycine. Estimates of
E,,, (maximal effect) and ECm (molar concentration of drug
producing 50% of its maximal effect) were calculated for gly-
cine and ACPC from concentration-response experiments by
non-linear regression analysis using the SigmaPlot computer
programme (Jandel, San Rafael, CA, U.S.A.).
Statistical analysis
Results represent mean+s.e.mean. Statistical differences be-
tween groups were analyzed with Student's paired t test;
P<0.05 was considered to be significant.
Drugs
The following drugs were used: (-)-[7,8-3H]-noradrenaline
(39 Ci mmol-1) was obtained from Amersham International,
N-methyl-D-aspartic acid and glycine from Sigma Chemical (St
Louis, MO, U.S.A.), 7-chlorokynurenic acid (7Kyn) from RBI
(Natick, MA, U.S.A.); 1-aminocyclopropanecarboxylic acid
(ACPC) from Tocris-Cookson (Bristol, U.K.).
Results
The spontaneous basal tritium efflux from synaptosomes pre-
pared from rat hippocampus and pre-incubated with [3H]-NA
in the first fraction collected (F1) was 1.29 + 0.04% (per 2 min)
of the total remaining radioactivity. In the absence of added
drugs, the ratio of % tritium efflux of the third over the first
fraction (F3/F1) was 0.87+0.02. NMDA (100 gM) stimulated
tritium release in the third fraction, raising the F3/F1 ratio to
1.18+0.04 which represents a 36% increase in F3/F1 ratio
when compared to unstimulated basal levels. Addition of
glycine (10 jM) potentiated the effects of NMDA on tritium
release and significantly increased the F3/F1 ratio by 27% to
1.50+0.07 (Figure 1). Similarly, the addition of ACPC
(0.1 pM) to the superfusion medium enhanced the NMDA-
evoked tritium release in the third fraction and increased the
F3/F1 ratio by 26% to 1.49 + 0.04. 7Kyn, an antagonist at the
glycine site of the NMDA receptor, at a concentration of
10 pM significantly antagonized the effects of both glycine and
ACPC. Furthermore, 7Kyn completely blocked the effect of
NMDA (100 pM) in the absence of added glycine, indicating
the presence of glycine either in the synaptosomal samples or
in the assay buffers (Figure 1).
Glycine produced a concentration-related increase in the
NMDA-evoked overflow of tritium, with an EC50 Of
1.82+0.04 gM and an E,, of 84+11% when compared to
effect of NMDA in the absence of added glycine. ACPC also
potentiated the effect ofNMDA but with a significantly lower
EC50 (43 + 6 nM) and a significantly lower maximal effect
(E,,,,= 40 +9%) when compared to glycine (Figure 2).
The concentration-response curve of glycine was also as-
sessed in the presence of fixed concentrations (0.1 nM and
0.1 gM) of ACPC to determine the partial agonist activity of
ACPC at the glycine modulatory site. The ECm of glycine,
which was 1.82+ 0.04 gM in the absence of ACPC, was in-
creased to 51+3 gM and >3 mm in the presence of 0.1 nM
and 0.1 M concentrations of ACPC respectively (Figure 3).
Discussion
NMDA increased tritium efflux in superfused rat hippocampal
synaptosomes. This increase reflects [3H]-NA release and was
potentiated by glycine and ACPC. The facilitatory effect of
both glycine and ACPC on NMDA-evoked [3H]-NA release
was prevented by the selective antagonist at the glycine site
7Kyn, indicating that it is mediated by the strychnine-
insensitive glycine site of the NMDA receptor complex.
Receptor binding experiments have shown that ACPC is a
competitive inhibitor of strychnine-insensitive [3H]-glycine
binding to the NMDA receptor in rat forebrain membranes
with an apparent affinity (Ki = 0.03 pM) that is approximately
three times higher than that of glycine (KD = 0.1 gM) (Marvi-
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Figure 1 Effects of ligands at the glycine site of the NMDA receptor
complex on the ratio of % 3H efflux in fraction 3 over % 3H efflux in
fraction 1 induced by 100pM NMDA in rat superfused hippocampal
synaptosomes. For the control group (no NMDA, no glycine), the
ratio of % tritium efflux of the third fraction over the first was
0.87+0.02, corresponding to 1.13+0.03% tritium efflux in the third
fraction (0.207 + 0.03 nCi). Values refer to 2-min fractions and
represent mean+s.e.mean of at least four experiments run in tri-
plicate. aP<0.001 versus control group; bp<0.001 versus NMDA;
cP<0.001 versus NMDA+glycine; P<0.001 versus NMDA+
ACPC.
902
M.V. Clos et al ACPC on 3H]-NA release
200 -
180 -
160 -
a)
C 140-c
0
120 -
100 -
-9 -8 -7 -6
log Drug (M)
-5 -4 -3
l
-8 -7 -6 -5 -4 -3 -2 -1
log [Glycinel (M)
Figure 2 Concentration-response curves for the effects of glycine
(0) and ACPC (0) on NMDA-induced tritium release (F3/F1
ratio). Modulation of NMDA-stimulated tritium release by glycine
and ACPC was assessed in superfused synaptosomes from rat
hippocampus. Values are the percentage of the tritium overflow
elicited by 100 uM NMDA in the absence of added glycine and ACPC
and represent mean+s.e.mean of at least four experiments run in
triplicate.
zon et al., 1989). The glycine and NMDA recognition sites of
the NMDA receptor complex are allosterically coupled. Gly-
cine facilitates the opening of the NMDA receptor channel
and, as a result, enhances the binding of compounds such as
[3H]-MK801 that bind to a site located within the NMDA
cation channel. Since ACPC has a lower E,,, (40%) than
glycine to enhance [3H]-MK801 binding to rat forebrain
membranes, it was suggested that ACPC is a partial agonist at
the glycine site of the NMDA receptor (Marvizon et al., 1989).
Electrophysiological studies performed in several laboratories
confirm this hypothesis but suggest that the estimation of the
intrinsic activity of ACPC at the strychnine-insensitive glycine
site may depend on the experimental assay system and the type
of functional NMDA receptor activity measured. Thus, elec-
trophysiological studies report intrinsic activity values for
ACPC between 77 and 95% compared to glycine, significantly
higher than the reported values in radioligand binding ex-
periments (McBain et al., 1989; Watson & Lanthorn, 1990;
Bashir et al., 1990; Priestley & Kemp, 1994).
In the present experiments, the E,. of ACPC for po-
tentiation of the effects of NMDA on synaptosomal [3H]-NA
release was 48% of the Emzt of glycine (Figure 2), a result that
it is more consistent with the intrinsic activity shown by ACPC
in enhancing [3H]-MK801 binding in receptor binding assays.
In our superfused hippocampal synaptosome preparation, the
potency of glycine in enhancing the effects ofNMDA on [3H]-
NA release was found to be somewhat lower (EC50 = 1.82 gM,
Figure 2) but within the range of the affinities reported in
electrophysiological experiments (EC50 = 0.7 + 0.1 gM, Kleck-
ner & Dingledine, 1988). However, ACPC showed an almost
thirty fold higher potency than glycine. These findings suggest
that ACPC exhibits lower maximal effect and higher potency
in presynaptic NMDA receptor assays than in assay prepara-
Figure 3 Concentration-response curves for the effect of glycine on
NMDA-induced tritium release in the presence of fixed concentra-
tions of ACPC. Modulation of NMDA-stimulated tritium release by
glycine was assessed in superfused synaptosomes from rat hippo-
campus exposed to NMDA (1001Mm) and various concentrations of
glycine in the absence (0) and in the presence of 0.1 nM (0) and
0.1 Mm (V) ACPC. ACPC was added to the superfusion medium
10min before NMDA and glycine. Values are the percentage of the
tritium overflow elicited by 100lM NMDA in the absence of added
glycine and ACPC and represent mean+s.e.mean of at least four
experiments run in triplicate. In the presence of 0.1jIM ACPC, the
concentration-response curve for glycine did not level off at high
concentrations. In this condition, the EC50 of glycine was estimated
to be > 3 mm. This estimate was calculated by using the effect
observed with 100mm glycine, the highest concentration that could
be reached in these experiments, as the maximal effect.
tions that contain either postsynaptic or mixed populations of
NMDA receptor subtypes. In support of this notion, the ap-
parent affinities of glycine site ligands have been shown to
differ remarkably among brain regions (Monaghan & Ander-
son, 1991) and the ligand binding affinities of NMDA re-
ceptors have been shown to depend on subunit composition
(Laurie & Seeburg, 1994).
Glycine is thought to be present continuously in the extra-
cellular space (McBain & Mayer, 1994). However, the phy-
siological contribution of the modulatory action of glycine to
the activity of the NMDA receptor complex in vivo remains
controversial. If occupation by glycine of the glycine site is
essential for activation of NMDA receptors, then a partial
agonist like ACPC may function as a glycine antagonist at
high glycine concentrations. In support of this interpretation,
the results reported in the present studies, showing that ACPC
(0.1 jIM) shifts the ECm of glycine to enhance NMDA-evoked
[3H]-NA release from 1.82 uM to > 3 mM, indicate that ACPC
may act as an antagonist at the glycine site of hippocampal
NMDA receptors.
In summary, the present results show that ACPC can reduce
the potentiation by glycine of NMDA-evoked [3H]-NA release
in a functional assay for presynaptic NMDA receptor activity
and suggest that a partial agonist like ACPC may act as an
antagonist at the glycine site of the NMDA receptor at high
glycine concentrations.
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